Atividade da fosfoetanolamina sintética em melanoma murino experimental / Activity of synthetic phosphoethanolamine in experimental murine melanoma
AUTOR(ES)
Luciana Chain Veronez
FONTE
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia
DATA DE PUBLICAÇÃO
06/11/2012
RESUMO
The low responsiveness of melanoma to traditional treatments together with its increasing incidence makes the development of new therapeutic strategies against this type of cancer extremely important. In this study, we used a murine melanoma model to evaluate the effects of synthetic phosphoethanolamine (PEA) on the development of this tumor. In vitro, PEA had an inhibitory effect on the proliferation of B16F10 cells, inducing apoptosis after 24 to 72h stimulation. In vivo, oral treatment of melanoma-bearing animals with different doses of PEA (10, 20 e 40mg/Kg) during 10 or 20 consecutive days resulted in reduced tumor volumes (at least 70% compared to the control) and in expressive macroscopic differences. PEA also induced a dose-dependent increase of apoptosis and decrease in tumor cell proliferation. The treatment also resulted in hematological changes, such as increased numbers of platelets, erythrocytes and leukocytes. Among leukocytes, we observed a higher proportion of lymphocytes and monocytes after 10 and 20 days of treatment, respectively. In addition, PEA induced higher levels of the pro-inflammatory cytokine IL-6 and of the anti-inflammatory cytokines IL-10 and TGF-, and it also induced a lower production of the pro-inflammatory cytokine IFN-. No differences were observed in the levels of IL-1, TNF-, IL-12p70 and IL-17 upon treatment. Our results demonstrate an inhibitory role of PEA in the development of melanoma, contributing to a better understanding of its antitumoral activity.
ASSUNTO(S)
fosfoetanolamina melanoma melanoma. phosphoethanolamine
Documentos Relacionados
- Efeitos antiproliferativos e apoptóticos da fosfoetanolamina sintética no melanoma B16F10
- Application pre-clinic of synthetic phosphoethanolamine on epilepsies experimental models
- Componentes derivados de venenos de serpentes com ação antitumoral em células de melanoma Murino
- Questões éticas sobre o ensaio clínico da fosfoetanolamina "sintética"
- Evidence for a dual role of galectin-3 in murine melanoma growth